Logo image of UNH.DE

UNITEDHEALTH GROUP INC (UNH.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:UNH - US91324P1021 - Common Stock

277.6 EUR
-6.85 (-2.41%)
Last: 12/22/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to UNH. UNH was compared to 33 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of UNH get a neutral evaluation. Nothing too spectacular is happening here. UNH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

UNH had positive earnings in the past year.
In the past year UNH had a positive cash flow from operations.
UNH had positive earnings in each of the past 5 years.
UNH had a positive operating cash flow in each of the past 5 years.
UNH.DE Yearly Net Income VS EBIT VS OCF VS FCFUNH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

1.2 Ratios

UNH has a Return On Assets of 5.58%. This is amongst the best in the industry. UNH outperforms 81.82% of its industry peers.
The Return On Equity of UNH (18.36%) is better than 90.91% of its industry peers.
The Return On Invested Capital of UNH (7.55%) is better than 75.76% of its industry peers.
UNH had an Average Return On Invested Capital over the past 3 years of 10.14%. This is above the industry average of 6.56%.
Industry RankSector Rank
ROA 5.58%
ROE 18.36%
ROIC 7.55%
ROA(3y)7.06%
ROA(5y)7.43%
ROE(3y)22.21%
ROE(5y)22.85%
ROIC(3y)10.14%
ROIC(5y)10.16%
UNH.DE Yearly ROA, ROE, ROICUNH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

UNH has a Profit Margin of 4.04%. This is in the better half of the industry: UNH outperforms 69.70% of its industry peers.
In the last couple of years the Profit Margin of UNH has declined.
UNH's Operating Margin of 6.06% is in line compared to the rest of the industry. UNH outperforms 54.55% of its industry peers.
In the last couple of years the Operating Margin of UNH has remained more or less at the same level.
Industry RankSector Rank
OM 6.06%
PM (TTM) 4.04%
GM N/A
OM growth 3Y-1.09%
OM growth 5Y-0.16%
PM growth 3Y-15.71%
PM growth 5Y-8.84%
GM growth 3YN/A
GM growth 5YN/A
UNH.DE Yearly Profit, Operating, Gross MarginsUNH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UNH is creating some value.
Compared to 1 year ago, UNH has less shares outstanding
Compared to 5 years ago, UNH has less shares outstanding
Compared to 1 year ago, UNH has a worse debt to assets ratio.
UNH.DE Yearly Shares OutstandingUNH.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
UNH.DE Yearly Total Debt VS Total AssetsUNH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

UNH has an Altman-Z score of 2.89. This is not the best score and indicates that UNH is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of UNH (2.89) is better than 69.70% of its industry peers.
UNH has a debt to FCF ratio of 4.61. This is a neutral value as UNH would need 4.61 years to pay back of all of its debts.
The Debt to FCF ratio of UNH (4.61) is better than 84.85% of its industry peers.
UNH has a Debt/Equity ratio of 0.76. This is a neutral value indicating UNH is somewhat dependend on debt financing.
UNH has a better Debt to Equity ratio (0.76) than 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 4.61
Altman-Z 2.89
ROIC/WACC0.87
WACC8.64%
UNH.DE Yearly LT Debt VS Equity VS FCFUNH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

A Current Ratio of 0.95 indicates that UNH may have some problems paying its short term obligations.
UNH has a Current ratio (0.95) which is comparable to the rest of the industry.
UNH has a Quick Ratio of 0.95. This is a bad value and indicates that UNH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of UNH (0.95) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
UNH.DE Yearly Current Assets VS Current LiabilitesUNH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The earnings per share for UNH have decreased strongly by -22.96% in the last year.
The Earnings Per Share has been growing by 13.07% on average over the past years. This is quite good.
UNH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.48%.
The Revenue has been growing by 10.57% on average over the past years. This is quite good.
EPS 1Y (TTM)-22.96%
EPS 3Y13.67%
EPS 5Y13.07%
EPS Q2Q%-59.16%
Revenue 1Y (TTM)10.48%
Revenue growth 3Y11.65%
Revenue growth 5Y10.57%
Sales Q2Q%12.24%

3.2 Future

UNH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.72% yearly.
The Revenue is expected to grow by 6.13% on average over the next years.
EPS Next Y-40.98%
EPS Next 2Y-19.86%
EPS Next 3Y-8.89%
EPS Next 5Y2.72%
Revenue Next Year11.62%
Revenue Next 2Y6.47%
Revenue Next 3Y6.02%
Revenue Next 5Y6.13%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UNH.DE Yearly Revenue VS EstimatesUNH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200B 400B 600B
UNH.DE Yearly EPS VS EstimatesUNH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10 20 30 40 50

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.52 indicates a correct valuation of UNH.
60.61% of the companies in the same industry are more expensive than UNH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of UNH to the average of the S&P500 Index (26.61), we can say UNH is valued slightly cheaper.
With a Price/Forward Earnings ratio of 18.18, UNH is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UNH indicates a slightly more expensive valuation: UNH is more expensive than 63.64% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of UNH to the average of the S&P500 Index (24.01), we can say UNH is valued slightly cheaper.
Industry RankSector Rank
PE 15.52
Fwd PE 18.18
UNH.DE Price Earnings VS Forward Price EarningsUNH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

UNH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. UNH is more expensive than 69.70% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UNH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 17
EV/EBITDA 11.37
UNH.DE Per share dataUNH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300 400

4.3 Compensation for Growth

UNH has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as UNH's earnings are expected to decrease with -8.89% in the coming years.
PEG (NY)N/A
PEG (5Y)1.19
EPS Next 2Y-19.86%
EPS Next 3Y-8.89%

5

5. Dividend

5.1 Amount

UNH has a Yearly Dividend Yield of 2.69%.
UNH's Dividend Yield is a higher than the industry average which is at 1.57.
Compared to an average S&P500 Dividend Yield of 1.87, UNH pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

On average, the dividend of UNH grows each year by 14.73%, which is quite nice.
Dividend Growth(5Y)14.73%
Div Incr Years5
Div Non Decr Years5
UNH.DE Yearly Dividends per shareUNH.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

44.61% of the earnings are spent on dividend by UNH. This is a bit on the high side, but may be sustainable.
UNH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP44.61%
EPS Next 2Y-19.86%
EPS Next 3Y-8.89%
UNH.DE Yearly Income VS Free CF VS DividendUNH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B
UNH.DE Dividend Payout.UNH.DE Dividend Payout, showing the Payout Ratio.UNH.DE Dividend Payout.PayoutRetained Earnings

UNITEDHEALTH GROUP INC

FRA:UNH (12/22/2025, 7:00:00 PM)

277.6

-6.85 (-2.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)01-27 2026-01-27/amc
Inst Owners83.6%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap251.46B
Revenue(TTM)435.16B
Net Income(TTM)17.59B
Analysts74.55
Price Target351.08 (26.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend6.99
Dividend Growth(5Y)14.73%
DP44.61%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.22%
Min EPS beat(2)-9.92%
Max EPS beat(2)3.48%
EPS beat(4)2
Avg EPS beat(4)-2.08%
Min EPS beat(4)-9.92%
Max EPS beat(4)3.48%
EPS beat(8)6
Avg EPS beat(8)0.38%
EPS beat(12)10
Avg EPS beat(12)0.9%
EPS beat(16)14
Avg EPS beat(16)1.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.91%
Min Revenue beat(2)-0.91%
Max Revenue beat(2)-0.91%
Revenue beat(4)0
Avg Revenue beat(4)-1.63%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.91%
Revenue beat(8)2
Avg Revenue beat(8)-0.68%
Revenue beat(12)5
Avg Revenue beat(12)-0.31%
Revenue beat(16)7
Avg Revenue beat(16)-0.21%
PT rev (1m)10.51%
PT rev (3m)18.24%
EPS NQ rev (1m)0.13%
EPS NQ rev (3m)1.16%
EPS NY rev (1m)0.24%
EPS NY rev (3m)0.69%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 15.52
Fwd PE 18.18
P/S 0.68
P/FCF 17
P/OCF 14.09
P/B 3.08
P/tB N/A
EV/EBITDA 11.37
EPS(TTM)17.89
EY6.44%
EPS(NY)15.27
Fwd EY5.5%
FCF(TTM)16.33
FCFY5.88%
OCF(TTM)19.7
OCFY7.1%
SpS409.02
BVpS90.03
TBVpS-35.1
PEG (NY)N/A
PEG (5Y)1.19
Graham Number190.37
Profitability
Industry RankSector Rank
ROA 5.58%
ROE 18.36%
ROCE 9.71%
ROIC 7.55%
ROICexc 8.39%
ROICexgc 23.23%
OM 6.06%
PM (TTM) 4.04%
GM N/A
FCFM 3.99%
ROA(3y)7.06%
ROA(5y)7.43%
ROE(3y)22.21%
ROE(5y)22.85%
ROIC(3y)10.14%
ROIC(5y)10.16%
ROICexc(3y)11.32%
ROICexc(5y)11.36%
ROICexgc(3y)32.46%
ROICexgc(5y)32.01%
ROCE(3y)13.1%
ROCE(5y)13.1%
ROICexgc growth 3Y-2.11%
ROICexgc growth 5Y-0.12%
ROICexc growth 3Y-2.38%
ROICexc growth 5Y-0.43%
OM growth 3Y-1.09%
OM growth 5Y-0.16%
PM growth 3Y-15.71%
PM growth 5Y-8.84%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 4.61
Debt/EBITDA 2.36
Cap/Depr 83.69%
Cap/Sales 0.82%
Interest Coverage 250
Cash Conversion 68.42%
Profit Quality 98.8%
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 2.89
F-Score9
WACC8.64%
ROIC/WACC0.87
Cap/Depr(3y)84.34%
Cap/Depr(5y)80.61%
Cap/Sales(3y)0.88%
Cap/Sales(5y)0.86%
Profit Quality(3y)124.43%
Profit Quality(5y)123.8%
High Growth Momentum
Growth
EPS 1Y (TTM)-22.96%
EPS 3Y13.67%
EPS 5Y13.07%
EPS Q2Q%-59.16%
EPS Next Y-40.98%
EPS Next 2Y-19.86%
EPS Next 3Y-8.89%
EPS Next 5Y2.72%
Revenue 1Y (TTM)10.48%
Revenue growth 3Y11.65%
Revenue growth 5Y10.57%
Sales Q2Q%12.24%
Revenue Next Year11.62%
Revenue Next 2Y6.47%
Revenue Next 3Y6.02%
Revenue Next 5Y6.13%
EBIT growth 1Y-18.15%
EBIT growth 3Y10.44%
EBIT growth 5Y10.4%
EBIT Next Year-24.66%
EBIT Next 3Y-3.48%
EBIT Next 5Y4.13%
FCF growth 1Y-34.26%
FCF growth 3Y0.99%
FCF growth 5Y4.56%
OCF growth 1Y-29.48%
OCF growth 3Y2.39%
OCF growth 5Y5.37%

UNITEDHEALTH GROUP INC / UNH.DE FAQ

Can you provide the ChartMill fundamental rating for UNITEDHEALTH GROUP INC?

ChartMill assigns a fundamental rating of 5 / 10 to UNH.DE.


What is the valuation status for UNH stock?

ChartMill assigns a valuation rating of 3 / 10 to UNITEDHEALTH GROUP INC (UNH.DE). This can be considered as Overvalued.


Can you provide the profitability details for UNITEDHEALTH GROUP INC?

UNITEDHEALTH GROUP INC (UNH.DE) has a profitability rating of 6 / 10.


What is the valuation of UNITEDHEALTH GROUP INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for UNITEDHEALTH GROUP INC (UNH.DE) is 15.52 and the Price/Book (PB) ratio is 3.08.


What is the financial health of UNITEDHEALTH GROUP INC (UNH.DE) stock?

The financial health rating of UNITEDHEALTH GROUP INC (UNH.DE) is 5 / 10.